Oriahnn is a medicine for heavy periods caused by fibroids in the uterus. It is taken as capsules by mouth every day. One part lowers the hormones that make fibroids bleed, and small doses of two other hormones help protect your bones.
Every report comes from a Lived member, sent anonymously.
Have you tried Oriahnn (Elagolix / Estradiol / Norethindrone) for Fibroids?
Oriahnn is a prescription medicine for heavy menstrual bleeding caused by uterine fibroids, the noncancerous growths in the muscle wall of the uterus. It is approved for adults who have not yet gone through menopause. It combines three ingredients: elagolix, which lowers the body's own reproductive hormones, plus low doses of estradiol (an estrogen) and norethindrone acetate (a progestin), added back to soften the side effects of that hormone drop. Oriahnn treats the bleeding rather than removing fibroids, and its use is limited to 24 months, so it is often considered by people who want to avoid or delay surgery, or who are approaching menopause. Orilissa contains elagolix alone and is a separate product approved for endometriosis pain, not fibroid bleeding. Myfembree is a different medicine built on the same idea (relugolix with estradiol and norethindrone acetate) and is also approved for fibroid bleeding.
Each month, a signal from the brain called gonadotropin-releasing hormone (GnRH) tells the pituitary gland to release the hormones that drive the ovaries. The ovaries then make estrogen and progesterone, which build up the uterine lining and help fibroids grow and bleed. Elagolix blocks GnRH from acting on the pituitary, so the ovaries make much less estrogen and progesterone, and periods become lighter or stop. Very low estrogen, however, causes hot flashes and thins the bones, much like menopause. The small dose of estradiol in Oriahnn is meant to limit that bone loss, and the norethindrone acetate protects the lining of the uterus from the effects of taking estrogen without a progestin. This add-back reduces the hormone-deprivation side effects, but it does not remove them entirely.
Oriahnn comes as two different capsules in one pack. The morning capsule (yellow and white) contains elagolix, estradiol and norethindrone acetate. The evening capsule (light blue and white) contains elagolix only. Take one of each every day at about the same times, with or without food. Treatment starts either after a pregnancy test or within 7 days of the start of a period. If a capsule is missed, it can be taken within 4 hours of the usual time; after that, skip it and take the next one as scheduled, never two at once. The total course is limited to 24 months.
Hot flashes are the most common side effect, reported by about one in five people in the main trials. Headache, tiredness and irregular spotting or bleeding are also common. Some people notice hair thinning, which was a reason some trial participants stopped and did not always resolve after stopping. Blood pressure, cholesterol and triglyceride levels can rise, and blood sugar can increase in people with diabetes or prediabetes. Oriahnn can lower mood. New or worsening depression or anxiety should be reported to the prescriber right away, and anyone having thoughts of suicide should contact the prescriber or get emergency help right away. Yellowing of the skin or eyes, dark urine or pain in the upper right abdomen can signal a liver problem and also need a prompt call. Because the estrogen and progestin raise clotting risk, stop taking Oriahnn and get emergency care for chest, arm or jaw pain or pressure, sudden shortness of breath, leg pain or swelling that will not go away, a sudden severe headache unlike usual ones, weakness or numbness on one side, trouble speaking, or sudden changes in vision.
Oriahnn carries the FDA's most serious (boxed) warning: like other estrogen and progestin combinations, it raises the risk of blood clots in the legs or lungs, stroke and heart attack. It is not prescribed to people over 35 who smoke, people with uncontrolled high blood pressure, or anyone with a past blood clot, stroke, heart attack, clotting disorder or migraine with aura after age 35. It is also not used with osteoporosis, liver disease, a current or past breast cancer or other hormone-sensitive cancer, or unexplained vaginal bleeding that has not been evaluated. If surgery or a long period of immobility is planned, the prescriber may pause it beforehand. Oriahnn does not prevent pregnancy, and pregnancy while taking it may raise the risk of early miscarriage. Lighter or absent periods can also hide a pregnancy. Use a non-hormonal method such as condoms during treatment and for 28 days after stopping; whether hormonal birth control changes how well Oriahnn works is unknown. Stop it and call the prescriber if pregnancy is possible. Several medicines interact with elagolix. Cyclosporine, a transplant and immune-suppressing medicine, and gemfibrozil, a triglyceride-lowering drug, can sharply raise elagolix levels and are ruled out with it. Medicines that strongly block the liver enzyme that breaks down elagolix, such as the antifungal ketoconazole, are not recommended, and neither is rifampin, an antibiotic used for tuberculosis. Other medicines fall into these groups too, so the pharmacist should screen every new prescription. Oriahnn can raise levels of digoxin, a heart medicine, and lower levels of rosuvastatin, a cholesterol drug. Avoid grapefruit and grapefruit juice. People on thyroid or cortisol replacement may need dose changes, so share a full medicine and supplement list.
In the two six-month trials that led to approval, about 69 and 77 percent of people taking Oriahnn reached the bleeding goal (losing less than 80 mL of blood per period and cutting blood loss at least in half), compared with about 10 percent on placebo. People who started out anemic were more likely to see their blood counts recover, usually alongside iron supplements. Not everyone responds, and the prescriber will judge progress from bleeding and blood tests. Follow-up includes regular blood pressure checks and, often, cholesterol tests. A DXA scan, a low-dose X-ray that measures bone density, is recommended at the start and periodically during treatment. Bone loss tends to grow with longer use and may not fully recover after stopping, which is why treatment is capped at 24 months. Calcium and vitamin D may help if diet falls short, taken at a different time from any iron. After stopping, periods usually return within a few months, and the fibroids themselves remain, so heavy bleeding can come back. Discussing the longer-term plan early, whether surgery, another treatment or reaching menopause, makes the end of the course easier to manage.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Oriahnn (Elagolix / Estradiol / Norethindrone), what you've noticed, or ask the community a question.